AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹171 Cr | ₹65 Cr | ₹9.72 Cr | ₹-163 Cr | ₹260 Cr |
What is the latest Cash Flow from Financing Activities ratio of AARTI PHARMALABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹171 Cr |
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹9.72 Cr |
| Mar2023 | ₹-163 Cr |
| Mar2022 | ₹260 Cr |
How is Cash Flow from Financing Activities of AARTI PHARMALABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹171 Cr | 160.69 | |
| Mar2025 | ₹65 Cr | 572.92 | |
| Mar2024 | ₹9.72 Cr | Positive | |
| Mar2023 | ₹-163 Cr | Negative | |
| Mar2022 | ₹260 Cr | - | |
Compare Cash Flow from Financing Activities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,978.9 Cr | 5.1% | -5.3% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 5.1% |
-5.3% |
-2.3% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses